Published in Am J Psychiatry on November 01, 2012
An Ethical Exploration of Barriers to Research on Controlled Drugs. Am J Bioeth (2016) 5.77
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry (2013) 4.84
Acute suppression of spontaneous neurotransmission drives synaptic potentiation. J Neurosci (2013) 1.43
Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med (2014) 1.39
Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc Natl Acad Sci U S A (2014) 1.26
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol (2013) 1.25
Antidepressant actions of ketamine: from molecular mechanisms to clinical practice. Curr Opin Neurobiol (2015) 1.22
Neuropathology of stress. Acta Neuropathol (2013) 1.14
Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties. Mol Psychiatry (2013) 1.12
Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res (2014) 1.09
Reelin mobilizes a VAMP7-dependent synaptic vesicle pool and selectively augments spontaneous neurotransmission. Neuron (2013) 1.07
Emerging links between homeostatic synaptic plasticity and neurological disease. Front Cell Neurosci (2013) 1.03
Rett Syndrome: Crossing the Threshold to Clinical Translation. Trends Neurosci (2016) 0.99
Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm (Vienna) (2013) 0.98
Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Transl Psychiatry (2014) 0.98
Miniature neurotransmission regulates Drosophila synaptic structural maturation. Neuron (2014) 0.95
Recent insights into the mode of action of memantine and ketamine. Curr Opin Pharmacol (2014) 0.94
Rapid antidepressant effects: moving right along. Mol Psychiatry (2013) 0.93
How does ketamine elicit a rapid antidepressant response? Curr Opin Pharmacol (2014) 0.92
Alterations in ethanol-induced behaviors and consumption in knock-in mice expressing ethanol-resistant NMDA receptors. PLoS One (2013) 0.86
Depression: the best way forward. Nature (2014) 0.86
Current status of ketamine and related compounds for depression. J Clin Psychiatry (2013) 0.86
Antidepressant mechanism of ketamine: perspective from preclinical studies. Front Neurosci (2015) 0.85
Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors. Neuropsychopharmacology (2015) 0.84
Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. ACS Chem Neurosci (2013) 0.83
Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry (2014) 0.83
Ketamine, sleep, and depression: current status and new questions. Curr Psychiatry Rep (2013) 0.82
Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel. Br J Pharmacol (2015) 0.82
Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function. Neuropharmacology (2014) 0.81
Role of membrane cholesterol in spontaneous exocytosis at frog neuromuscular synapses: reactive oxygen species-calcium interplay. J Physiol (2014) 0.80
NMDA receptor antagonist ketamine impairs feature integration in visual perception. PLoS One (2013) 0.80
Roles of Presynaptic NMDA Receptors in Neurotransmission and Plasticity. Trends Neurosci (2015) 0.79
New insights into BDNF signaling: relevance to major depression and antidepressant action. Am J Psychiatry (2012) 0.79
HCN Channel Targets for Novel Antidepressant Treatment. Neurotherapeutics (2017) 0.79
NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum. Transl Psychiatry (2014) 0.78
Klotho sensitivity of the neuronal excitatory amino acid transporters EAAT3 and EAAT4. PLoS One (2013) 0.78
Epistatic interaction of genetic depression risk variants in the human subgenual cingulate cortex during memory encoding. Transl Psychiatry (2014) 0.78
NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER. Transl Neurosci (2013) 0.78
Lurasidone exerts antidepressant properties in the chronic mild stress model through the regulation of synaptic and neuroplastic mechanisms in the rat prefrontal cortex. Int J Neuropsychopharmacol (2014) 0.78
GSK-3: a key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput. Bipolar Disord (2016) 0.77
Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat. Br J Pharmacol (2015) 0.77
Homer1/mGluR5 activity moderates vulnerability to chronic social stress. Neuropsychopharmacology (2015) 0.77
NMDA receptor as a newly identified member of the metabotropic glutamate receptor family: clinical implications for neurodegenerative diseases. Mol Cells (2013) 0.77
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine. Curr Neuropharmacol (2017) 0.77
Structural Basis for the Recognition of Eukaryotic Elongation Factor 2 Kinase by Calmodulin. Structure (2016) 0.77
Pushing the threshold: How NMDAR antagonists induce homeostasis through protein synthesis to remedy depression. Brain Res (2016) 0.76
Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy. Depress Res Treat (2015) 0.76
Altered overnight modulation of spontaneous waking EEG reflects altered sleep homeostasis in major depressive disorder: a high-density EEG investigation. J Affect Disord (2013) 0.76
Ketamine: NMDA Receptors and Beyond. J Neurosci (2016) 0.75
In vivo imaging of CREB phosphorylation in awake-mouse brain. Sci Rep (2015) 0.75
The interactive effects of ketamine and magnesium upon depressive-like pathology. Neuropsychiatr Dis Treat (2016) 0.75
A Clickable Analogue of Ketamine Retains NMDA Receptor Activity, Psychoactivity, and Accumulates in Neurons. Sci Rep (2016) 0.75
Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons. J Psychopharmacol (2015) 0.75
Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders. Mol Psychiatry (2017) 0.75
Existing and novel biological therapeutics in suicide prevention. Am J Prev Med (2014) 0.75
Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression. Psychopharmacology (Berl) (2016) 0.75
Stakeholders' Views on Barriers to Research on Controversial Controlled Substances. J Clin Ethics (2016) 0.75
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science (2006) 9.31
A neurotrophic model for stress-related mood disorders. Biol Psychiatry (2006) 8.97
Neurobiology of depression. Neuron (2002) 8.56
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature (2011) 6.40
Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry (2007) 2.93
Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature (2003) 2.86
Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev (2012) 2.54
MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol (2006) 2.25
Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci (2008) 2.18
Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci (2005) 2.18
Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry (2005) 2.14
MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc Natl Acad Sci U S A (2008) 2.09
Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci (2007) 1.79
Repeated administration of amphetamine or cocaine does not alter AMPA receptor subunit expression in the rat midbrain. Neuropsychopharmacology (2002) 1.61
Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. J Neurosci (2009) 1.58
MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome. J Neurosci (2009) 1.50
Role of GluR1 expression in nucleus accumbens neurons in cocaine sensitization and cocaine-seeking behavior. Eur J Neurosci (2008) 1.44
Acute suppression of spontaneous neurotransmission drives synaptic potentiation. J Neurosci (2013) 1.43
mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci (2013) 1.43
In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. PLoS One (2012) 1.40
Temporally regulated expression of Cre recombinase in neural stem cells. Genesis (2005) 1.38
An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci (2012) 1.35
The impact of MeCP2 loss- or gain-of-function on synaptic plasticity. Neuropsychopharmacology (2012) 1.22
Stress and disease: is being female a predisposing factor? J Neurosci (2007) 1.18
Loss of histone deacetylase 2 improves working memory and accelerates extinction learning. J Neurosci (2013) 1.18
A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission. J Neurosci (2012) 1.18
Gender-specific impact of brain-derived neurotrophic factor signaling on stress-induced depression-like behavior. Biol Psychiatry (2009) 1.16
Behavioral epigenetics. Ann N Y Acad Sci (2011) 1.14
Reelin mobilizes a VAMP7-dependent synaptic vesicle pool and selectively augments spontaneous neurotransmission. Neuron (2013) 1.07
Regulation of serotonin-1A receptor function in inducible brain-derived neurotrophic factor knockout mice after administration of corticosterone. Biol Psychiatry (2007) 1.07
Use-dependent AMPA receptor block reveals segregation of spontaneous and evoked glutamatergic neurotransmission. J Neurosci (2011) 1.06
Histone deacetylases govern cellular mechanisms underlying behavioral and synaptic plasticity in the developing and adult brain. Behav Pharmacol (2010) 1.00
Reinforcement-related regulation of AMPA glutamate receptor subunits in the ventral tegmental area enhances motivation for cocaine. J Neurosci (2011) 0.99
Epigenetics in the mature mammalian brain: effects on behavior and synaptic transmission. Neurobiol Learn Mem (2011) 0.98
The role of MeCP2 in CNS development and function. Horm Behav (2010) 0.97
Epigenetics and psychiatry. Neurotherapeutics (2013) 0.96
Selective impact of MeCP2 and associated histone deacetylases on the dynamics of evoked excitatory neurotransmission. J Neurophysiol (2011) 0.93
Regional, cellular, and subcellular localization of RGS10 in rodent brain. J Comp Neurol (2005) 0.92
Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor. Biol Psychiatry (2005) 0.91
Unique functional roles for class I and class II histone deacetylases in central nervous system development and function. Int J Dev Neurosci (2013) 0.90
Role of MeCP2, DNA methylation, and HDACs in regulating synapse function. J Neurodev Disord (2011) 0.88
Epigenetics in suicide and depression. Biol Psychiatry (2009) 0.87
Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice. Int J Neuropsychopharmacol (2012) 0.87
Adenosine A1 and dopamine d1 receptor regulation of AMPA receptor phosphorylation and cocaine-seeking behavior. Neuropsychopharmacology (2013) 0.81
VGF, a new player in antidepressant action? Sci Signal (2008) 0.81
Induction of the plasticity-associated immediate early gene Arc by stress and hallucinogens: role of brain-derived neurotrophic factor. Int J Neuropsychopharmacol (2012) 0.79
Circadian rhythms: Depression brought to light. Nature (2012) 0.78
Toward neurotrophin-based therapeutics. Am J Psychiatry (2011) 0.77
Reciprocal interaction of serotonin and neuronal activity in regulation of cAMP-responsive element-dependent gene expression. J Pharmacol Exp Ther (2005) 0.77
Synergistic interactions between histone deacetylase inhibitors and drugs of abuse. Neuropsychopharmacology (2009) 0.76
It is time to take a stand for medical research and against terrorism targeting medical scientists. Biol Psychiatry (2008) 0.75